iVeena
Sarah Molokhia has over 12 years in ocular drug delivery experience. Most recently, Sarah was working as a Research Consultant with Aciont, Inc. an ocular drug delivery company in clinical trials. After completing her B.S in pharmacy school, she achieved her Ph.D. in pharmaceutical chemistry, University of Utah under the supervision of Dr. William I. Higuchi. Her research focus was on transscleral iontophoresis, ocular imaging and ocular pharmacokinetics. She then joined the Moran Eye Center for a postdoctoral position for 2 years working on intraocular drug delivery implants and conjugation of biomarkers to proteins for imaging.
This person is not in any offices
iVeena
Keratoconus, progressive myopia, and development of cystoid macular edema are areas of major unmet medical need. iVeena is developing two platform technologies in cornea and cataract — including topical delivery of copper and drug delivery from the lens capsule respectively. These novel approaches provide impactful and minimally invasive solutions for patients and physicians.